- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Scholar Rock Holding Corp (SRRK)
Assess today's live Scholar Rock Holding Corp (SRRK) share price, performance and insights using our live NASDAQ: SRRK stock exchange data.
Analyse the historical data and Scholar Rock Holding Corp share price performance charts on this page. Our technical summary section provides analysis on Scholar Rock share price buy/sell indicators using real-time data (or discuss the Scholar Rock (SRRK) stock price today with other investors in the Scholar Rock NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ SRRK share price (ISIN: US80706P1030) to enhance your trading decisions with our free investment tools and resources.
What Is the Scholar Rock Holding Corp Share Price Today?
The Scholar Rock share price today is 42.69.
What Is the Stock Symbol for Scholar Rock Holding Corp
The stock symbol (or 'ticker') for Scholar Rock Holding Corp is "SRRK."
What Stock Exchange Does Scholar Rock Holding Corp Trade On?
Scholar Rock Holding Corp is listed and trades on the NASDAQ stock exchange.
Is Scholar Rock Holding Corp a Good Stock to Buy?
Determining whether Scholar Rock Holding Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Scholar Rock Holding Corp share price performance charts on this page. Our technical summary section provides analysis on Scholar Rock share price buy/sell indicators using real-time data (or discuss the Scholar Rock (SRRK) stock price today with other investors in the Scholar Rock NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ SRRK share price (ISIN: US80706P1030) to enhance your trading decisions with our free investment tools and resources.
What Is the Scholar Rock Holding Corp Share Price Today?
The Scholar Rock share price today is 42.69.
What Is the Stock Symbol for Scholar Rock Holding Corp
The stock symbol (or 'ticker') for Scholar Rock Holding Corp is "SRRK."
What Stock Exchange Does Scholar Rock Holding Corp Trade On?
Scholar Rock Holding Corp is listed and trades on the NASDAQ stock exchange.
Is Scholar Rock Holding Corp a Good Stock to Buy?
Determining whether Scholar Rock Holding Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
42.69
+1.54(+3.74%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
40.89
42.95
52 wk Range
6.76
46.98
SRRK Scorecard
Full Analysis
2 analysts have revised their earnings downwards for the upcoming period
SRRK is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
40.8942.95
52 wk Range
6.7646.98
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SRRK Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
49.88
Upside
+16.83%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in overbought territory
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Scholar Rock Company Profile
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Its transforming growth factor beta (TGFß) superfamily biology, its novel understanding of the molecular mechanisms of growth factor activation enabled us to develop a proprietary platform for development of monoclonal antibodies that locally and selectively target the precursor. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is developing a pipeline of product candidates to deliver novel therapies to treat a range of serious diseases, including neuromuscular disorders, cardiometabolic disorders, cancer, fibrosis, and iron-restricted anemia. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts.
Scholar Rock Holding Corp SWOT Analysis
Pivotal Trial Awaits | Scholar Rock's SAPPHIRE trial for apitegromab in SMA nears completion, with potential to revolutionize treatment and drive significant market valuation |
Oncology Breakthrough | SRK-181 shows promise in overcoming resistance to immune checkpoint inhibitors, addressing a critical challenge in cancer treatment |
Expanding Horizons | Scholar Rock ventures into the lucrative obesity market with EMBRAZE trial and SRK-439, diversifying its pipeline beyond core focus areas |
Financial Outlook | Analyst targets range from $29 to $31, with potential for significant upside if pivotal trials succeed, despite current lack of revenue-generating assets |
Scholar Rock Holding Corp Earnings Call Summary for Q1/2025
- Scholar Rock reported Q1 2025 EPS of -0.67, slightly missing forecast of -0.66; stock rose 0.92% in premarket trading to $31.69
- FDA granted Priority Review for ipilimumab with PDUFA date set for September 22, 2025; US launch planned for Q3 2025
- Company ended Q1 with $364.4 million cash, extending runway into 2027; additional $100 million available under debt facility
- Exploring additional indications for products in neuromuscular disorders; EPS forecasts show continued R&D investment
- Analyst price targets range from $45 to $57, reflecting optimistic expectations for future performance
Last Updated: 14/05/2025, 14:14
Read Full TranscriptCompare SRRK to Peers and Sector
Metrics to compare | SRRK | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSRRKPeersSector | |
|---|---|---|---|---|
P/E Ratio | −14.8x | −1.5x | −0.5x | |
PEG Ratio | 0.70 | −0.02 | 0.00 | |
Price/Book | 12.5x | 0.6x | 2.6x | |
Price / LTM Sales | - | 65.9x | 3.2x | |
Upside (Analyst Target) | 21.5% | 215.5% | 45.4% | |
Fair Value Upside | Unlock | 12.2% | 6.7% | Unlock |
Analyst Ratings
9 Buy
0 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 49.88
(+16.83% Upside)
Earnings
Latest Release
May 14, 2025
EPS / Forecast
-0.67 / -0.66
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Scholar Rock (SRRK) Share Price Today?
The live Scholar Rock share price today is 42.69
What Stock Exchange Does Scholar Rock (SRRK) Trade On?
Scholar Rock is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Scholar Rock?
The stock symbol (also called a 'ticker') for Scholar Rock is "SRRK."
What Is the Current Scholar Rock Market Cap?
As of today, Scholar Rock market capitalisation is 4.00B.
What Is Scholar Rock's (SRRK) Earnings Per Share (TTM)?
The Scholar Rock EPS is currently -2.78 (Trailing Twelve Months).
When Is the Next Scholar Rock Earnings Date?
Scholar Rock's next earnings report will be released on 05 Aug 2025.
Is SRRK a Buy or Sell From a Technical Analyst Perspective?
Based on today's Scholar Rock moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Scholar Rock Stock Split?
Scholar Rock has split 0 times. (See the SRRK stock split history page for full effective split date and price information.)
How Many Employees Does Scholar Rock Have?
Scholar Rock currently has 128 employees.
What is the current trading status of Scholar Rock (SRRK)?
As of 17 Jul 2025, Scholar Rock (SRRK) is trading at a price of 42.69, with a previous close of 41.15. The stock has fluctuated within a day range of 40.89 to 42.95, while its 52-week range spans from 6.76 to 46.98.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.